A detailed history of Strategic Financial Concepts, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Strategic Financial Concepts, LLC holds 206,172 shares of NVO stock, worth $22.2 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
206,172
Previous 1,689 12106.75%
Holding current value
$22.2 Million
Previous $217 Million 97.69%
% of portfolio
0.0%
Previous 0.05%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 06, 2024

BUY
$122.71 - $146.91 $25.1 Million - $30 Million
204,483 Added 12106.75%
206,172 $5.02 Million
Q1 2024

Apr 22, 2024

BUY
$102.11 - $135.92 $172,463 - $229,568
1,689 New
1,689 $217 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $243B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Strategic Financial Concepts, LLC Portfolio

Follow Strategic Financial Concepts, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Strategic Financial Concepts, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Strategic Financial Concepts, LLC with notifications on news.